Pure Global

Isocitrate dehydrogenase 1 (IDH1) gene mutation IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Isocitrate dehydrogenase 1 (IDH1) gene mutation IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 159441. The device is manufactured by Abbott Molecular Inc. from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Abbott Laboratories Limited.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Isocitrate dehydrogenase 1 (IDH1) gene mutation IVD, kit, nucleic acid technique (NAT)
MHRA Device ID: 159441โ€ขRef: 159441

Device Type

In Vitro Diagnostic Device

Devices

Isocitrate dehydrogenase 1 (IDH1) gene mutation IVD, kit, nucleic acid technique (NAT)

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Apr 25, 2024

Manufacturer Information

Address

1350 E. Touhy Ave

Des Plaines, IL, Illinois, United States

Created Date

Mar 29, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

Abbott House, Vanwall Business Park, Vanwall Road

Maidenhead, Berkshire, England, United Kingdom

Postcode: SL64XE

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing